Display options
Cite
De Paschale M, Agrappi C, Manco MT, et al. Implementation of Screening for Toxoplasma gondii Infection in Pregnancy. J Clin Med Res. 2010;2(3):112-6doi: 10.4021/jocmr2010.05.321w.
De Paschale, M., Agrappi, C., Manco, M. T., Cerulli, T., & Clerici, P. (2010). Implementation of Screening for Toxoplasma gondii Infection in Pregnancy. Journal of clinical medicine research, 2(3), 112-6. https://doi.org/10.4021/jocmr2010.05.321w
De Paschale, Massimo, et al. "Implementation of Screening for Toxoplasma gondii Infection in Pregnancy." Journal of clinical medicine research vol. 2,3 (2010): 112-6. doi: https://doi.org/10.4021/jocmr2010.05.321w
De Paschale M, Agrappi C, Manco MT, Cerulli T, Clerici P. Implementation of Screening for Toxoplasma gondii Infection in Pregnancy. J Clin Med Res. 2010 May 19;2(3):112-6. doi: 10.4021/jocmr2010.05.321w. PMID: 21629522; PMCID: PMC3104638.
Copy Download .nbib Format: NLM
Share it on

J Clin Med Res. 2010 May 19;2(3):112-6. doi: 10.4021/jocmr2010.05.321w.

Implementation of Screening for Toxoplasma gondii Infection in Pregnancy.

Journal of clinical medicine research

Massimo De Paschale, Carlo Agrappi, Maria Teresa Manco, Teresa Cerulli, Pierangelo Clerici

Affiliations

  1. Microbiology Unit, Hospital of Legnano, Milan, Italy.

PMID: 21629522 PMCID: PMC3104638 DOI: 10.4021/jocmr2010.05.321w

Abstract

BACKGROUND: Since 1998, Italian law requires serological screening for toxoplasmosis by the thirteenth week of pregnancy, and seronegative women should undergo further checks every 30 - 40 days until delivery (a total of 5 - 7 screenings). This is an improvement of the previous law which foresaw three free tests (one by the end of the third month, one in the fifth, and one in the ninth month of pregnancy). The aim of this study was to assess the implementation, in an urban area of Northern Italy, of the 1998 law about 10 years after its entry into force.

METHODS: Of the 4,694 women who initiated and completed a pregnancy in the period 2006 - 2008, we recorded the trimester of pregnancy in which they underwent their first screening, the total and average number of screenings during pregnancy, and the trimester distribution of the screenings.

RESULTS: A total of 84.1% of the women underwent their first screening during the first trimester. The negative cases underwent an average of 3.7 screenings during pregnancy, with 34.9% undergoing five or more. Sixty percent of the women underwent at least one screening per trimester.

CONCLUSIONS: Our data indicates active screening during the first trimester, but fewer screenings than required by law during pregnancy as a whole. Therefore further efforts are needed to improve screening implementation.

KEYWORDS: Anti-Toxoplasma antibodies; Congenital infection; Pregnancy trimester; Toxoplasma screening; Seroconversion; Seronegative women; Seropositive women; Screening protocol.

References

  1. Scand J Infect Dis Suppl. 1992;84:32-7 - PubMed
  2. Ann Pediatr (Paris). 1984 Nov;31(10):805-9 - PubMed
  3. Ann Ig. 2003 Sep-Oct;15(5):505-14 - PubMed
  4. J Med Screen. 2003;10(4):172-5 - PubMed
  5. Eur J Epidemiol. 1995 Jun;11(3):333-7 - PubMed
  6. Lancet. 1999 May 29;353(9167):1829-33 - PubMed
  7. Clin Ter. 1996 Jun;147(6):317-20 - PubMed
  8. J Med Screen. 2002;9(3):135-41 - PubMed
  9. Scand J Infect Dis Suppl. 1992;84:38-42 - PubMed
  10. J Med Screen. 1996;3(4):188-94 - PubMed
  11. N Engl J Med. 1988 Feb 4;318(5):271-5 - PubMed
  12. Microbiologica. 1991 Jul;14(3):229-34 - PubMed
  13. Eur J Epidemiol. 1993 May;9(3):341-3 - PubMed

Publication Types